Cyclooxygenase-2 Expression in Right- and Left-Sided Colon Cancer: A Rationale For Optimization of Cyclooxygenase-2 Inhibitor Therapy
Authors:
- Hans E. KaiserHKHans E. Kaiser
- David BoulwareDBDavid Boulware
- Ardeshir HakamAHArdeshir Hakam
- Helena ZhaoHZHelena Zhao
- Timothy YeatmanTYTimothy Yeatman
- James BarthelJBJames Barthel
- Domenico CoppolaDCDomenico Coppola
- 1 February 2004
- journal article
- Published by Elsevier in Clinical Colorectal Cancer
- Vol. 3 (4) , 243-247
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Hereditary Colorectal CancerNew England Journal of Medicine, 2003
- Analysis of K- ras Codon 12 Mutation in Flat and Nodular Variants of Serrated Adenoma in the ColonDiseases of the Colon & Rectum, 2003
- Frequent loss of SMAD4/DPC4 protein in colorectal cancersGut, 2002
- Overexpression of cyclooxygenase-2 (COX-2) in human primitive neuroectodermal tumors: effect of celecoxib and rofecoxibCancer Letters, 2002
- COX-2 inhibitors in cancer treatment and prevention, a recent developmentAnti-Cancer Drugs, 2002
- Expression of Cyclooxygenase-2 Is Associated with Carcinogenesis of the Lower Part of Thoracic Esophageal Squamous Cell Carcinoma and p53 ExpressionOncology, 2002
- A model for p53-induced apoptosisNature, 1997
- Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancersNature Genetics, 1996
- The DCC Gene: Structural Analysis and Mutations in Colorectal CarcinomasGenomics, 1994
- Multistage Carcinogenesis: Population-Based Model for Colon CancerJNCI: Journal of the National Cancer Institute, 1992